206 related articles for article (PubMed ID: 23236027)
1. Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis.
Borz B; Durand E; Godin M; Tron C; Canville A; Litzler PY; Bessou JP; Cribier A; Eltchaninoff H
Heart; 2013 Jun; 99(12):860-5. PubMed ID: 23236027
[TBL] [Abstract][Full Text] [Related]
2. Prospective analysis of 30-day safety and performance of transfemoral transcatheter aortic valve implantation with Edwards SAPIEN XT versus SAPIEN prostheses.
Eltchaninoff H; Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A
Arch Cardiovasc Dis; 2012 Mar; 105(3):132-40. PubMed ID: 22520795
[TBL] [Abstract][Full Text] [Related]
3. Incidence and predictors of left bundle branch block after transcatheter aortic valve implantation.
Aktug Ö; Dohmen G; Brehmer K; Koos R; Altiok E; Deserno V; Herpertz R; Autschbach R; Marx N; Hoffmann R
Int J Cardiol; 2012 Sep; 160(1):26-30. PubMed ID: 21458085
[TBL] [Abstract][Full Text] [Related]
4. Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantation.
Gasparetto V; Fraccaro C; Tarantini G; Buja P; D'Onofrio A; Yzeiraj E; Pittarello D; Isabella G; Gerosa G; Iliceto S; Napodano M
Catheter Cardiovasc Interv; 2013 Feb; 81(2):376-83. PubMed ID: 22461314
[TBL] [Abstract][Full Text] [Related]
5. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience.
Godino C; Maisano F; Montorfano M; Latib A; Chieffo A; Michev I; Al-Lamee R; Bande M; Mussardo M; Arioli F; Ielasi A; Cioni M; Taramasso M; Arendar I; Grimaldi A; Spagnolo P; Zangrillo A; La Canna G; Alfieri O; Colombo A
JACC Cardiovasc Interv; 2010 Nov; 3(11):1110-21. PubMed ID: 21087745
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter aortic valve implantation (TAVI) outcome according to standardized endpoint definitions by the Valve Academic Research Consortium (VARC).
Stähli BE; Bünzli R; Grünenfelder J; Bühler I; Felix C; Bettex D; Biaggi P; Tanner FC; Nguyen-Kim DL; Plass A; Ge H; Falk V; Lüscher TF; Corti R; Maier W; Altwegg LA
J Invasive Cardiol; 2011 Aug; 23(8):307-12. PubMed ID: 21828390
[TBL] [Abstract][Full Text] [Related]
7. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes.
Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A; Eltchaninoff H
JACC Cardiovasc Interv; 2012 May; 5(5):461-467. PubMed ID: 22560979
[TBL] [Abstract][Full Text] [Related]
8. Transapical minimally invasive aortic valve implantation and conventional aortic valve replacement in octogenarians.
Strauch JT; Scherner M; Haldenwang PL; Madershahian N; Pfister R; Kuhn EW; Liakopoulos OJ; Wippermann J; Wahlers T
Thorac Cardiovasc Surg; 2012 Jul; 60(5):335-42. PubMed ID: 22547302
[TBL] [Abstract][Full Text] [Related]
9. Assessment of inflammatory response to transfemoral transcatheter aortic valve implantation compared to transapical and surgical procedures: a pilot study.
Stähli BE; Grünenfelder J; Jacobs S; Falk V; Landmesser U; Wischnewsky MB; Lüscher TF; Corti R; Maier W; Altwegg LA
J Invasive Cardiol; 2012 Aug; 24(8):407-11. PubMed ID: 22865312
[TBL] [Abstract][Full Text] [Related]
10. PREVAIL TRANSAPICAL: multicentre trial of transcatheter aortic valve implantation using the newly designed bioprosthesis (SAPIEN-XT) and delivery system (ASCENDRA-II).
Walther T; Thielmann M; Kempfert J; Schroefel H; Wimmer-Greinecker G; Treede H; Wahlers T; Wendler O
Eur J Cardiothorac Surg; 2012 Aug; 42(2):278-83; discussion 283. PubMed ID: 22293620
[TBL] [Abstract][Full Text] [Related]
11. The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation: results from the German Transcatheter Aortic Valve Interventions Registry.
Sinning JM; Horack M; Grube E; Gerckens U; Erbel R; Eggebrecht H; Zahn R; Linke A; Sievert H; Figulla HR; Kuck KH; Hauptmann KE; Hoffmann E; Hambrecht R; Richardt G; Sack S; Senges J; Nickenig G; Werner N
Am Heart J; 2012 Jul; 164(1):102-10.e1. PubMed ID: 22795289
[TBL] [Abstract][Full Text] [Related]
12. Transfemoral aortic valve implantation new criteria to predict vascular complications.
Hayashida K; Lefèvre T; Chevalier B; Hovasse T; Romano M; Garot P; Mylotte D; Uribe J; Farge A; Donzeau-Gouge P; Bouvier E; Cormier B; Morice MC
JACC Cardiovasc Interv; 2011 Aug; 4(8):851-8. PubMed ID: 21851897
[TBL] [Abstract][Full Text] [Related]
13. Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve.
Mussardo M; Latib A; Chieffo A; Godino C; Ielasi A; Cioni M; Takagi K; Davidavicius G; Montorfano M; Maisano F; Carlino M; Franco A; Covello RD; Spagnolo P; Grimaldi A; Alfieri O; Colombo A
JACC Cardiovasc Interv; 2011 Jul; 4(7):743-50. PubMed ID: 21777881
[TBL] [Abstract][Full Text] [Related]
14. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation.
Sinning JM; Ghanem A; Steinhäuser H; Adenauer V; Hammerstingl C; Nickenig G; Werner N
JACC Cardiovasc Interv; 2010 Nov; 3(11):1141-9. PubMed ID: 21087750
[TBL] [Abstract][Full Text] [Related]
15. [POL-TAVI First--Polish report on transcatheter aortic valve implantation (TAVI) of Edwards-Sapien prosthesis in the first 19 high risk patients with severe aortic stenosis and comorbidities].
Zembala M; Wilczek K; Przybylski R; Chodór P; Nadziakiewicz P; Krasoń M; Sadowski J; Dudek D; Kapelak B; Forysz D; Witkowski A; Demkow M; Chmielak Z; Kuśmierski K; Juraszyński Z; Bochenek A; Cisowski M; Trusz-Gluza M; Buszman P; Woś S; Kalarus Z; Poloński L; Gasior M; Opolski G; Ruzyłło W
Kardiol Pol; 2009 Aug; 67(8):936-40. PubMed ID: 19784896
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis.
Ussia GP; Barbanti M; Petronio AS; Tarantini G; Ettori F; Colombo A; Violini R; Ramondo A; Santoro G; Klugmann S; Bedogni F; Maisano F; Marzocchi A; Poli A; De Carlo M; Napodano M; Fiorina C; De Marco F; Antoniucci D; de Cillis E; Capodanno D; Tamburino C;
Eur Heart J; 2012 Apr; 33(8):969-76. PubMed ID: 22240494
[TBL] [Abstract][Full Text] [Related]
17. Worldwide experience with the 29-mm Edwards SAPIEN XT™ transcatheter heart valve in patients with large aortic annulus.
Wendler O; Thielmann M; Schroefel H; Rastan A; Treede H; Wahlers T; Eichinger W; Walther T
Eur J Cardiothorac Surg; 2013 Feb; 43(2):371-7. PubMed ID: 22522982
[TBL] [Abstract][Full Text] [Related]
18. Quality of life in high-risk patients: comparison of transcatheter aortic valve implantation with surgical aortic valve replacement.
Amonn K; Stortecky S; Brinks H; Gahl B; Windecker S; Wenaweser P; Carrel T; Huber C
Eur J Cardiothorac Surg; 2013 Jan; 43(1):34-41; discussion 41-2. PubMed ID: 22531274
[TBL] [Abstract][Full Text] [Related]
19. The incidence of transcatheter aortic valve implantation-related heart block in self-expandable Medtronic CoreValve and balloon-expandable Edwards valves.
Liang M; Devlin G; Pasupati S
J Invasive Cardiol; 2012 Apr; 24(4):173-6. PubMed ID: 22477754
[TBL] [Abstract][Full Text] [Related]
20. Acute and late outcomes of Transcatheter Aortic Valve Implantation (TAVI) for the treatment of severe symptomatic aortic stenosis in patients at high- and low-surgical risk.
Schymik G; Schröfel H; Schymik JS; Wondraschek R; Süselbeck T; Kiefer R; Balthasar V; Luik A; Posival H; Schmitt C
J Interv Cardiol; 2012 Aug; 25(4):364-74. PubMed ID: 22624865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
